Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma

Darcy Kerr, Kshitij S. Arora, Krishnan K. Mahadevan, Jason L. Hornick, Jeffrey F. Krane, Miguel N. Rivera, David T. Ting, Vikram Deshpande, William C. Faquin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

High-risk human papillomavirus (HR-HPV) is a major etiologic agent in a subset of head and neck squamous cell carcinomas (HNSCCs), and its recognition has prognostic and predictive implications. The availability of a sensitive and specific test to assess HR-HPV status is limited. We evaluate an RNA in situ hybridization (ISH) method using branch chain technology to detect HR-HPV and compare its results with DNA ISH, p16 immunohistochemistry, and polymerase chain reaction (PCR). Tissue sections from 54 patients were stained with a manual RNA ISH assay (ViewRNA), which detects 14 HR-HPV types, an automated DNA ISH assay, and p16 immunohistochemistry. Most cases (83%, n=45) were also tested on an automated platform for 14 HR-HPV types and 1 limited to HPV 16/18. PCR was performed in all cases and was successful in 93% (n=50). The RNA ISH assay produced results in 96% of the cases with strong signals and was easily interpreted. HR-HPV was detected in more cases (63%, n=34) by RNA ISH than by DNA ISH (39%, n=21). Compared with PCR, both ISH platforms were 94% specific. RNA ISH was more sensitive (91%) than DNA ISH (65%), and RNA ISH correlated more strongly with p16 immunostaining. HPV 16 represented 89% of HR-HPV detected. The cocktail HPV 16/18 platform was concordant with the pooled HR-HPV assay in all expected cases. The automated assay demonstrated high concordance (96%) with the manual version, showed decreased background, and should allow for easy implementation into the workflow of the diagnostic pathology laboratory.

Original languageEnglish (US)
Pages (from-to)1643-1652
Number of pages10
JournalAmerican Journal of Surgical Pathology
Volume39
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

In Situ Hybridization
RNA
Human papillomavirus 16
Human papillomavirus 18
DNA
Polymerase Chain Reaction
Carcinoma, squamous cell of head and neck
Immunohistochemistry
Workflow
Pathology
Technology

Keywords

  • head and neck cancer
  • human papillomavirus (HPV)
  • in situ hybridization (ISH)
  • p16
  • squamous cell carcinoma
  • testing methods

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma. / Kerr, Darcy; Arora, Kshitij S.; Mahadevan, Krishnan K.; Hornick, Jason L.; Krane, Jeffrey F.; Rivera, Miguel N.; Ting, David T.; Deshpande, Vikram; Faquin, William C.

In: American Journal of Surgical Pathology, Vol. 39, No. 12, 01.12.2015, p. 1643-1652.

Research output: Contribution to journalArticle

Kerr, Darcy ; Arora, Kshitij S. ; Mahadevan, Krishnan K. ; Hornick, Jason L. ; Krane, Jeffrey F. ; Rivera, Miguel N. ; Ting, David T. ; Deshpande, Vikram ; Faquin, William C. / Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma. In: American Journal of Surgical Pathology. 2015 ; Vol. 39, No. 12. pp. 1643-1652.
@article{1c65b1d238234820a937796a9432d1c6,
title = "Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma",
abstract = "High-risk human papillomavirus (HR-HPV) is a major etiologic agent in a subset of head and neck squamous cell carcinomas (HNSCCs), and its recognition has prognostic and predictive implications. The availability of a sensitive and specific test to assess HR-HPV status is limited. We evaluate an RNA in situ hybridization (ISH) method using branch chain technology to detect HR-HPV and compare its results with DNA ISH, p16 immunohistochemistry, and polymerase chain reaction (PCR). Tissue sections from 54 patients were stained with a manual RNA ISH assay (ViewRNA), which detects 14 HR-HPV types, an automated DNA ISH assay, and p16 immunohistochemistry. Most cases (83{\%}, n=45) were also tested on an automated platform for 14 HR-HPV types and 1 limited to HPV 16/18. PCR was performed in all cases and was successful in 93{\%} (n=50). The RNA ISH assay produced results in 96{\%} of the cases with strong signals and was easily interpreted. HR-HPV was detected in more cases (63{\%}, n=34) by RNA ISH than by DNA ISH (39{\%}, n=21). Compared with PCR, both ISH platforms were 94{\%} specific. RNA ISH was more sensitive (91{\%}) than DNA ISH (65{\%}), and RNA ISH correlated more strongly with p16 immunostaining. HPV 16 represented 89{\%} of HR-HPV detected. The cocktail HPV 16/18 platform was concordant with the pooled HR-HPV assay in all expected cases. The automated assay demonstrated high concordance (96{\%}) with the manual version, showed decreased background, and should allow for easy implementation into the workflow of the diagnostic pathology laboratory.",
keywords = "head and neck cancer, human papillomavirus (HPV), in situ hybridization (ISH), p16, squamous cell carcinoma, testing methods",
author = "Darcy Kerr and Arora, {Kshitij S.} and Mahadevan, {Krishnan K.} and Hornick, {Jason L.} and Krane, {Jeffrey F.} and Rivera, {Miguel N.} and Ting, {David T.} and Vikram Deshpande and Faquin, {William C.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1097/PAS.0000000000000516",
language = "English (US)",
volume = "39",
pages = "1643--1652",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma

AU - Kerr, Darcy

AU - Arora, Kshitij S.

AU - Mahadevan, Krishnan K.

AU - Hornick, Jason L.

AU - Krane, Jeffrey F.

AU - Rivera, Miguel N.

AU - Ting, David T.

AU - Deshpande, Vikram

AU - Faquin, William C.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - High-risk human papillomavirus (HR-HPV) is a major etiologic agent in a subset of head and neck squamous cell carcinomas (HNSCCs), and its recognition has prognostic and predictive implications. The availability of a sensitive and specific test to assess HR-HPV status is limited. We evaluate an RNA in situ hybridization (ISH) method using branch chain technology to detect HR-HPV and compare its results with DNA ISH, p16 immunohistochemistry, and polymerase chain reaction (PCR). Tissue sections from 54 patients were stained with a manual RNA ISH assay (ViewRNA), which detects 14 HR-HPV types, an automated DNA ISH assay, and p16 immunohistochemistry. Most cases (83%, n=45) were also tested on an automated platform for 14 HR-HPV types and 1 limited to HPV 16/18. PCR was performed in all cases and was successful in 93% (n=50). The RNA ISH assay produced results in 96% of the cases with strong signals and was easily interpreted. HR-HPV was detected in more cases (63%, n=34) by RNA ISH than by DNA ISH (39%, n=21). Compared with PCR, both ISH platforms were 94% specific. RNA ISH was more sensitive (91%) than DNA ISH (65%), and RNA ISH correlated more strongly with p16 immunostaining. HPV 16 represented 89% of HR-HPV detected. The cocktail HPV 16/18 platform was concordant with the pooled HR-HPV assay in all expected cases. The automated assay demonstrated high concordance (96%) with the manual version, showed decreased background, and should allow for easy implementation into the workflow of the diagnostic pathology laboratory.

AB - High-risk human papillomavirus (HR-HPV) is a major etiologic agent in a subset of head and neck squamous cell carcinomas (HNSCCs), and its recognition has prognostic and predictive implications. The availability of a sensitive and specific test to assess HR-HPV status is limited. We evaluate an RNA in situ hybridization (ISH) method using branch chain technology to detect HR-HPV and compare its results with DNA ISH, p16 immunohistochemistry, and polymerase chain reaction (PCR). Tissue sections from 54 patients were stained with a manual RNA ISH assay (ViewRNA), which detects 14 HR-HPV types, an automated DNA ISH assay, and p16 immunohistochemistry. Most cases (83%, n=45) were also tested on an automated platform for 14 HR-HPV types and 1 limited to HPV 16/18. PCR was performed in all cases and was successful in 93% (n=50). The RNA ISH assay produced results in 96% of the cases with strong signals and was easily interpreted. HR-HPV was detected in more cases (63%, n=34) by RNA ISH than by DNA ISH (39%, n=21). Compared with PCR, both ISH platforms were 94% specific. RNA ISH was more sensitive (91%) than DNA ISH (65%), and RNA ISH correlated more strongly with p16 immunostaining. HPV 16 represented 89% of HR-HPV detected. The cocktail HPV 16/18 platform was concordant with the pooled HR-HPV assay in all expected cases. The automated assay demonstrated high concordance (96%) with the manual version, showed decreased background, and should allow for easy implementation into the workflow of the diagnostic pathology laboratory.

KW - head and neck cancer

KW - human papillomavirus (HPV)

KW - in situ hybridization (ISH)

KW - p16

KW - squamous cell carcinoma

KW - testing methods

UR - http://www.scopus.com/inward/record.url?scp=84948716767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948716767&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000516

DO - 10.1097/PAS.0000000000000516

M3 - Article

VL - 39

SP - 1643

EP - 1652

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 12

ER -